RT Journal Article
SR Electronic
T1 Twelve-year changes in protein profiles in patients with and without gastric bypass surgery
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.13.20173666
DO 10.1101/2020.08.13.20173666
A1 Yousri, Noha A.
A1 Engelke, Rudolf
A1 Sarwath, Hina
A1 McKinlay, Rodrick D.
A1 Simper, Steven C.
A1 Adams, Ted D.
A1 Schmidt, Frank
A1 Suhre, Karsten
A1 Hunt, Steven C.
YR 2020
UL http://medrxiv.org/content/early/2020/08/14/2020.08.13.20173666.abstract
AB Gastric bypass surgery results in long-term weight loss due to re-routing of the gastro-intestinal anatomy and dietary intake alterations. Studies have examined protein change during rapid weight loss (up to 1 year post-surgery), but whether protein changes are maintained long-term after weight stabilization is unknown. To identify proteins and pathways involved with the long-term beneficial effects of weight loss, abundances of 1297 blood-circulating proteins were measured at baseline, 2 and 12 years after Roux-en-Y gastric bypass surgery. Protein changes were compared between 234 surgery and 144 non-surgery subjects with severe obesity, with discovery and replication subgroups. Seventy-one protein changes were associated with 12-year BMI changes and 58 (7 unique) with surgical status. Protein changes, including ApoM, were most strongly associated with long-term changes in lipids (HDL-C and triglycerides). Inflammation, adipogenesis, cellular signaling, and complement pathways were implicated. Short-term improvements in protein levels were maintained long-term, even after some weight regain.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a proteomics study on gastric bypass surgery patientsFunding StatementSupported by a grant (DK-55006) from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, a U.S. Public Health Service research grant (MO1-RR00064) from the National Center for Research Resources, Biomedical Research Program funds from Intermountain Healthcare, and from Qatar Foundation to Weill Cornell Medicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All subjects provided written informed consent and the study was approved by the University of Utah Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are present in tables in the manuscript and supplementary tables,figures.